Fujisawa, Japan

Mitsunori Kouno

This inventor holds 2 USPTO granted patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2010-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsunori Kouno. Retrieved from https://idiyas.com/inventor/mitsunori-kouno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Osaka, JP (2010)
  • Fujisawa, JP (2017)

Company Filing History:


Years Active: 2010-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitsunori Kouno: Innovator in Pharmaceutical Chemistry

Introduction

Mitsunori Kouno is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Kouno holds 2 patents that showcase his innovative work. His latest patents include a heterocyclic compound that exhibits RORγt inhibitory action. This invention relates to a compound represented by a specific formula, which includes various structural components. Another significant patent is for a brain/neuronal cell-protecting agent and therapeutic agent for sleep disorders. This compound is designed to protect brain cells and treat sleep disorders, featuring a complex formula with multiple substituents.

Career Highlights

Kouno is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda emphasizes the importance of research and development in creating effective therapeutic agents.

Collaborations

Throughout his career, Kouno has collaborated with esteemed colleagues, including Atsuko Ochida and Masakuni Kori. These collaborations have contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Mitsunori Kouno's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of therapeutic agents that address critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…